Intermediate of tranexamic Acid-13C2,15N
Intermediate of tranexamic Acid-13C2,15N (Aminomethylbenzoic acid-13C2,15N) is 13C and 15N labeled 4- (Aminomethyl) benzoic acid. 4- (Aminomethyl) benzoic acid is a competitive inhibitor of PepT1 and has antifibrinolytic activity[1].
Product Specifications
Product Name Alternative
Aminomethylbenzoic acid-13C2,15N; α-Amino-p-toluic acid-13C2,15N
UNSPSC
12352005
Target
Amino Acid Derivatives; Isotope-Labeled Compounds
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=[13C](C1=CC=C([13C]([H])([H])[15NH2])C=C1)O
Molecular Formula
C6 13C2H9 15NO2
Molecular Weight
154.14
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Darcel N P, et al. Activation of vagal afferents in the rat duodenum by protein digests requires PepT1[J]. The Journal of nutrition, 2005, 135 (6) : 1491-1495.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880304-500 1x 500 µL
CD106 / VCAM1 (B-K9), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680745-100 1x 100 µL
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940679-100 1x 100 µL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040828-100 1x 100 µL
CD79a (JCB117 + HM47/A9), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details